Loading clinical trials...

The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT05093478

The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population

The purpose of this study to determine the therapeutic response of non-allergic rhinitis patients that have been subtyped as non-allergic rhinitis with local IgE elevation or non-allergic rhinopathy t...

Lead sponsor: The University of Texas Health Science Center, Houston•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis

NCT03399721 · Nasal Congestion, Non-allergic Rhinitis

COMPLETEDNA

Detection and Use of Nasal Nitrous Oxide and the Electronic Nose

NCT02476929 · Allergic Rhinitis, Non-Allergic Rhinitis, and more

COMPLETED

Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand

NCT02000648 · Allergic Rhinitis, Non-allergic Rhinitis, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 20, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment28

Start dateSep 2019

Last updatedDec 20, 2024

Condition

Non-allergic Rhinitis

Locations shown

The University of Texas Health Science Center at Houston

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions